[1]
U. Kılıçaslan and F. A. Hapa, “Retrospective Analysis of Demographic and Clinical Data of Psoriasis Patients Who Developed Inflammatory Bowel Disease Under Secukinumab and Ixekizumab Treatment”, Dermatol Pract Concept, vol. 16, p. 7125, Apr. 2026, doi: 10.5826/dpc.160a7125.